Ixekizumab Provides Persistent Improvements in Health‐related Quality of Life and the Sexual Impact Associated with Moderate‐to‐severe Genital Psoriasis in Adult Patients During a 52‐week, Randomised, Placebo‐controlled, Phase 3 Clinical Trial
JEADV Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要